Orthopediatrics (KIDS) EBIT Margin (2016 - 2026)
Orthopediatrics' (KIDS) quarterly EBIT Margin came in at 14.04% in Q1 2026, up 691.0% year-on-year from 1.78% in Q1 2025, and down 5.85% on a QoQ basis from 13.27% in Q4 2025.
Orthopediatrics (KIDS) EBIT Margin (2016 - 2026) Analysis & Trends
Orthopediatrics (KIDS) has 11 years of EBIT Margin data on file, last reported at 14.04% in Q1 2026.
- On a quarterly basis, EBIT Margin rose 691.0% year-over-year to 14.04% in Q1 2026; TTM through Mar 2026 was 15.04%, a 203.0% increase from a year earlier, with the FY2025 full-year figure at 16.6%, up 50.0% from the prior year.
- EBIT Margin for Q1 2026 stood at 14.04%, down from 13.27% in the prior quarter.
- Over the last five years, EBIT Margin for KIDS reached as high as 10.2% in Q3 2024 and fell as low as 27.27% in Q1 2022.
- Historically, EBIT Margin has averaged 18.23% across 5 years, with a median of 17.45% in 2025.
- On a YoY basis, EBIT Margin climbed as much as 1342 bps in 2025 and fell as far as 672 bps in 2025.
- Year by year, EBIT Margin stood at 26.81% in 2022, then grew by 20 bps to 21.44% in 2023, then decreased by 24 bps to 26.69% in 2024, then jumped by 50 bps to 13.27% in 2025, then fell by 6 bps to 14.04% in 2026.
- Per Business Quant data, the three most recent EBIT Margin figures were 14.04% in Q1 2026, 13.27% in Q4 2025, and 15.39% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Orthopediatrics | 443.38 Mn | 429.14 Mn | 43.39 Mn | -14.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.04% |
| Dec 31, 2025 | -13.27% |
| Sep 30, 2025 | -15.39% |
| Jun 30, 2025 | -17.45% |
| Mar 31, 2025 | -20.95% |
| Dec 31, 2024 | -26.69% |
| Sep 30, 2024 | -10.20% |
| Jun 30, 2024 | -10.73% |
| Mar 31, 2024 | -21.76% |
| Dec 31, 2023 | -21.44% |
| Sep 30, 2023 | -11.28% |
| Jun 30, 2023 | -14.12% |
| Mar 31, 2023 | -27.20% |
| Dec 31, 2022 | -26.81% |
| Sep 30, 2022 | -19.92% |
| Jun 30, 2022 | -11.37% |
| Mar 31, 2022 | -27.27% |
| Dec 31, 2021 | -22.41% |
| Sep 30, 2021 | -14.53% |
| Jun 30, 2021 | -10.66% |